GlassScriptPhysician profile
Demetrios N Macris
NPI 1801892930
$7,111.11
in general payments reported to CMS, 2019-2025
29 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,977 · 2020: $993 · 2021: $629 · 2022: $872 · 2023: $684 · 2024: $795 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,639.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,303.67 | 2019-2020 | |
| Biotronik INC. | $1,763.38 | 2022-2025 | Pulsar-18 T3, Passeo-18, Orsiro Mission |
| Angiodynamics, INC. | $461.12 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $460.49 | 2021 | |
| Bard Peripheral Vascular, INC. | $381.70 | 2019-2024 | Lutonix Drug Coated Balloon |
| Tactile Systems Technology INC | $238.56 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Teleflex LLC | $218.38 | 2020-2025 | Orsiro Mission, Manta, Pulsar-18 T3 |
| Endologix LLC | $193.66 | 2024-2025 | Endocross Device, Torus Stent Graft System |
| Silk Road Medical, INC. | $157.21 | 2022 | |
| Shockwave Medical, INC | $124.99 | 2021 | |
| Organogenesis INC. | $124.41 | 2019 | |
| Philips North America LLC | $93.18 | 2019-2022 | |
| Boston Scientific Corporation | $86.17 | 2019-2024 | |
| Cardiva Medical, INC. | $82.03 | 2022 | |
| W. L. Gore & Associates, INC. | $62.89 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $54.84 | 2019 | |
| Microtransponder, INC. | $45.82 | 2025 | |
| Kerecis Limited | $44.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Veryan Medical Incorporated | $34.09 | 2025 | Biomimics 3d Vascular Stent System |
| Cordis US Corp. | $33.55 | 2022 | |
| Lemaitre Vascular, INC. | $24.86 | 2024 | Artegraft Vascular Graft |
| Bolton Medical INC | $20.76 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Cook Medical LLC | $19.75 | 2023 | Performer |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $16.68 | 2019 | |
| Neuros Medical, INC. | $16.50 | 2025 | Altius |
| Pfizer INC. | $14.24 | 2021 | |
| Abbvie INC. | $12.15 | 2022 | |
| Smith+Nephew, INC. | $11.24 | 2021 | |
| Cardiovascular Systems INC. | $10.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demetrios Macris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.